The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 15, 2022
Filed:
Aug. 23, 2018
Applicant:
Bavarian Nordic A/s, Kvistgaard, DK;
Inventors:
Hubertus Hochrein, Munich, DE;
Henning Lauterbach, Eching, DE;
José Medina Echeverz, Munich, DE;
Matthias Habjan, Gauting, DE;
Assignee:
Bavarian Nordic A/S, Hellerup, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/285 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001106 (2018.08); A61K 39/001152 (2018.08); A61K 39/285 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/57 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/70 (2013.01);
Abstract
The invention relates to a pharmaceutical combination and related methods for reducing tumor volume and/or increasing the survival of a cancer patient. The combination comprises an intravenous administration of a recombinant MVA encoding a tumor-associated antigen and an administration of an antibody to a cancer patient.
Hochrein, Hubertus. (2022). Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an antibody (U.S. Patent No. 11273211). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11273211
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile